From hacking the human genome to editing organs

REFERENCES

• Jaenisch RM, B. Simian Virus 40 DNA Sequences in DNA of Healthy Adult Mice Derived from Preimplantation Blastocysts Injected with Viral DNA. Proc Natl Acad Sci 1974; 71(4):1250-4; PMID:4364530; http://dx.doi.org/10.1073/pnas.71.4.1250
   PubMed Web of Science ®Google Scholar
• Smithies O, Gregg RG, Boggs SS, Koralewski MA, Kucherlapati RS. Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination. Nature 1985; 317:230-4; PMID:2995814; http://dx.doi.org/10.1038/317230a0
   PubMed Web of Science ®Google Scholar
• Robertson E, Bradley A, Kuehn M, Martin Evans. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 1986; 323:445-8; PMID:3762693; http://dx.doi.org/10.1038/323445a0
   PubMed Web of Science ®Google Scholar
• Friedmann T, Roblin R. Gene therapy for human genetic disease? Science 1972; 174(4025):949-55; http://dx.doi.org/10.1126/science.175.4025.949
   Web of Science ®Google Scholar
• Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, et al. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 1995; 20(270):475-80; http://dx.doi.org/10.1126/science.270.5235.475
   Web of Science ®Google Scholar
• Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, et al. Gene Therapy of Human Severe Combined Immunodeficiency (SCID)–X1 Disease. Science 2000; 288:699-72; http://dx.doi.org/10.1126/science.288.5466.669
   Web of Science ®Google Scholar
• Check E. A tragic setback. Nature 2002; 420:116-8
   PubMed Web of Science ®Google Scholar
• Miller J, McLachlan AD, Klug A. Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J 1985; 4(6):1609-14; PMID:4040853
   PubMed Web of Science ®Google Scholar
• Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 2010; 11(9):636-46; PMID:20717154; http://dx.doi.org/10.1038/nrg2842
   PubMed Web of Science ®Google Scholar
• Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U. Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors. Science 2009; 326:1509-12; PMID:19933107; http://dx.doi.org/10.1126/science.1178811
   PubMed Web of Science ®Google Scholar
• Baker M. Method of the Year 2012. Nature Methods 2012; 9(1):1-1; http://dx.doi.org/10.1038/nmeth.1852
   PubMed Web of Science ®Google Scholar
• Joung JK, Sander JD. TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 2013; 14(1):49-55; PMID:23169466; http://dx.doi.org/10.1038/nrm3486
   PubMed Web of Science ®Google Scholar
• Ishino Y S H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 1987; 169(12):5429-33; PMID:3316184
   PubMed Web of Science ®Google Scholar
• Barrangou R. Cas9 Targeting and the CRISPR Revolution. Science 2014; 344:707-8; PMID:24833384; http://dx.doi.org/10.1126/science.1252964
   PubMed Web of Science ®Google Scholar
• Meyer M, Ortiz O, Hrabe de Angelis M, Wurst W, Kuhn R. Modeling disease mutations by gene targeting in one-cell mouse embryos. Proc Natl Acad Sci U S A 2012; 109(24):9354-9; PMID:22660928; http://dx.doi.org/10.1073/pnas.1121203109
   PubMed Web of Science ®Google Scholar
• Wefers B, Meyer M, Ortiz O, Hrabé de Angelis M, Hansen J, Wurst W, Kühn R. Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides. PNAS 2013; 110(10):3782-7; PMID:23426636; http://dx.doi.org/10.1073/pnas.1218721110
   PubMed Web of Science ®Google Scholar
• Fujii W, Kawasaki K, Sugiura K, Naito K. Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease. Nucleic Acids Res 2013; 41(20):e187; PMID:23997119; http://dx.doi.org/10.1093/nar/gkt772
   PubMed Web of Science ®Google Scholar
• Soldner F, Laganiere J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, Khurana V, Golbe LI, Myers RH, Lindquist S, et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011; 146(2):318-31; PMID:21757228; http://dx.doi.org/10.1016/j.cell.2011.06.019
   PubMed Web of Science ®Google Scholar
• Ding Q, Lee YK, Schaefer EA, Peters DT, Veres A, Kim K, Kuperwasser N, Motola DL, Meissner TB, Hendriks WT, et al. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 2013; 12(2):238-51; PMID:23246482; http://dx.doi.org/10.1016/j.stem.2012.11.011
   PubMed Web of Science ®Google Scholar
• Piganeau M, Ghezraoui H, De Cian A, Guittat L, Tomishima M, Perrouault L, René O, Katibah GE, Zhang L, Holmes MC, et al. Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Res 2013; 23(7):1182-93; PMID:23568838; http://dx.doi.org/10.1101/gr.147314.112
   PubMed Web of Science ®Google Scholar
• Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004; 428:431-7; PMID:15042092; http://dx.doi.org/10.1038/nature02371
   PubMed Web of Science ®Google Scholar
• Jiang D, Zhao L, Clapham DE. Genome-Wide RNAi Screen Identifies Letm1 as a Mitochondrial Ca2+/H+ Antiporter. Science 2009; 326(5949):144-7; PMID:19797662; http://dx.doi.org/10.1126/science.1175145
   PubMed Web of Science ®Google Scholar
• Carette JE, Guimaraes CP, Varadarajan M, Park AS, Wuethrich I, Godarova A, Kotecki M, Cochran BH, Spooner E, Ploegh HL, et al. Haploid Genetic Screens in Human Cells Identify Host Factors Used by Pathogens. Science 2009; 326:1231-5; PMID:19965467; http://dx.doi.org/10.1126/science.1178955
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhu S, Cai C, Yuan P, Li C, Huang Y, Wei W. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature 2014; 509(7501):487-91; PMID:24717434; http://dx.doi.org/10.1038/nature13166
   PubMed Web of Science ®Google Scholar
• Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic Screens in Human Cells Using the CRISPR-Cas9 System. Science 2014; 343:80-4; PMID:24336569; http://dx.doi.org/10.1126/science.1246981
   PubMed Web of Science ®Google Scholar
• Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells. Science 2014; 343:84-7; PMID:24336571; http://dx.doi.org/10.1126/science.1247005
   PubMed Web of Science ®Google Scholar
• Koike-Yusa H, Li Y, Tan EP, Velasco-Herrera Mdel C, Yusa K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol 2014; 32(3):267-73; PMID:24535568; http://dx.doi.org/10.1038/nbt.2800
   PubMed Web of Science ®Google Scholar
• Xia Y, Nivet E, Sancho-Martinez I, Gallegos T, Suzuki K, Okamura D, Wu MZ, Dubova I, Esteban CR, Montserrat N, et al. Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells. Nat Cell Biol 2013; 15(12):1507-15; PMID:24240476; http://dx.doi.org/10.1038/ncb2872
   PubMed Web of Science ®Google Scholar
• Schwank G, Koo BK, Sasselli V, Dekkers JF, Heo I, Demircan T, Sasaki N, Boymans S, Cuppen E, van der Ent CK, et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 2013; 13(6):653-8; PMID:24315439; http://dx.doi.org/10.1016/j.stem.2013.11.002
   PubMed Web of Science ®Google Scholar
• Ito R, Takahashi T, Katano I, Ito M. Current advances in humanized mouse models. Cell Mol Immunol 2012; 9(3):208-14; PMID:22327211; http://dx.doi.org/10.1038/cmi.2012.2
   PubMed Web of Science ®Google Scholar
• Azuma H, Paulk N, Ranade A, Dorrell C, Al-Dhalimy M, Ellis E, Strom S, Kay MA, Finegold M, Grompe M. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 2007; 25(8):903-10; PMID:17664939; http://dx.doi.org/10.1038/nbt1326
   PubMed Web of Science ®Google Scholar
• Bility MT, Cheng L, Zhang Z, Luan Y, Li F, Chi L et al. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog 2014; 10(3):e1004032; PMID:24651854; http://dx.doi.org/10.1371/journal.ppat.1004032
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Yamaguchi T, Hamanaka S, Kato-Itoh M, Yamazaki Y, Ibata M, Sato H, Lee YS, Usui J, Knisely AS, et al. Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells. Cell 2010; 142(5):787-99; PMID:20813264; http://dx.doi.org/10.1016/j.cell.2010.07.039
   PubMed Web of Science ®Google Scholar
• Brehm MA, Shultz LD, Greiner DL. Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes 2010; 17(2):120-5; PMID:20150806; http://dx.doi.org/10.1097/MED.0b013e328337282f
   PubMed Web of Science ®Google Scholar
• Zhou J, Shen B, Zhang W, Wang J, Yang J, Chen L, Zhang N, Zhu K, Xu J, Hu B, et al. One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR/Cas9 mediated genome engineering. Int J Biochem Cell Biol 2014; 46:49-55; PMID:24269190; http://dx.doi.org/10.1016/j.biocel.2013.10.010
   PubMed Web of Science ®Google Scholar
• Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, Jamieson AC, Porteus MH, Gregory PD, Holmes MC. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005; 435:646-51; PMID:15806097; http://dx.doi.org/10.1038/nature03556
   PubMed Web of Science ®Google Scholar
• Genovese P, Schiroli G, Escobar G, Di Tomaso T, Firrito C, Calabria A, Moi D, Mazzieri R, Bonini C, Holmes MC, et al. Targeted genome editing in human repopulating haematopoietic stem cells. Nature; 510:235-40; PMID:24870228; http://dx.doi.org/10.1038/nature13420
   PubMed Web of Science ®Google Scholar
• Yusa K, Rashid ST, Strick-Marchand H, Varela I, Liu PQ, Paschon DE, Miranda E, Ordóñez A, Hannan NR, Rouhani FJ, et al. Targeted gene correction of α 1 -antitrypsin deficiency in induced pluripotent stem cells. Nature 2011; 478:391-4; PMID:21993621; http://dx.doi.org/10.1038/nature10424
   PubMed Web of Science ®Google Scholar
• Chang CJ, Bouhassira EE. Zinc-finger nuclease-mediated correction of α-thalassemia in iPS cells. Gene therapy 2012; 120:3906-14
   Google Scholar
• Zou J S C, Chou BK, Choi U, Pan J, Wang H, Dowey SN, Cheng L, Malech HL. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells : functional correction by zinc finger nuclease – mediated safe harbor targeting. Blood 2011; 117(21):5561-72; PMID:21411759; http://dx.doi.org/10.1182/blood-2010-12-328161
   PubMed Web of Science ®Google Scholar
• Sun N, Zhao H. Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs. Biotechnol Bioeng 2014; 111(5):1048-53; PMID:23928856; http://dx.doi.org/10.1002/bit.25018
   PubMed Web of Science ®Google Scholar
• Li H, Haurigot V, Doyon Y, Li T, Wong SY, Bhagwat AS, Malani N, Anguela XM, Sharma R, Ivanciu L, et al. In vivo genome editing restores hemostasis in a mouse model of hemophilia. Nature 2010; 475:217-21; http://dx.doi.org/10.1038/nature10177
   Web of Science ®Google Scholar
• Sharma R, Anguela XM, Doyon Y, Wechsler T, DeKelver RC, Sproul S, Paschon DE, Miller JC, Davidson RJ, Shivak D, et al. In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood 2015; 126(15):1777-84; PMID:26297739; http://dx.doi.org/10.1182/blood-2014-12-615492
   PubMed Web of Science ®Google Scholar
• Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, Spratt SK, Surosky RT, Giedlin MA, Nichol G, et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 2014; 370(10):901-10; PMID:24597865; http://dx.doi.org/10.1056/NEJMoa1300662
   PubMed Web of Science ®Google Scholar
• Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, et al. Long-Term Control of HIV by CCR5 Delta32/ Delta32 Stem-Cell Transplantation. N Engl J Med 2009; 370(7):392-8
   Google Scholar
• Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O, Wang N, Lee G, Bartsevich VV, Lee YL, et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 2008; 26:808-16; PMID:18587387; http://dx.doi.org/10.1038/nbt1410
   PubMed Web of Science ®Google Scholar
• Bloom K, Ely A, Mussolino C, Cathomen T, Arbuthnot P. Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther 2013; 21(10):1889-97; PMID:23883864; http://dx.doi.org/10.1038/mt.2013.170
   PubMed Web of Science ®Google Scholar
• Rebar EJ, Huang Y, Hickey R, Nath AK, Meoli D, Nath S, Chen B, Xu L, Liang Y, Jamieson AC, et al. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med 2002; 8(12):1427-32; PMID:12415262; http://dx.doi.org/10.1038/nm1202-795
   PubMed Web of Science ®Google Scholar
• Maddalo D, Manchado E, Concepcion CP, Bonetti C, Vidigal JA, Han YC, Ogrodowski P, Crippa A, Rekhtman N, de Stanchina E, et al. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 2014; 516(7531):423-7; PMID:25337876; http://dx.doi.org/10.1038/nature13902
   PubMed Web of Science ®Google Scholar
• Ledford H. CRISPR, the disruptor. Nature 2015; 522(7554):20-4; PMID:26040877; http://dx.doi.org/10.1038/522020a
   PubMed Web of Science ®Google Scholar
• Gullans JEaS. Genetically enhanced Olympics are coming. Nature 2012; 487:297; PMID:22810679; http://dx.doi.org/10.1038/487297a
   PubMed Web of Science ®Google Scholar
• Liang P, Xu Y, Zhang X, Ding C, Huang R, Zhang Z, Lv J, Xie X, Chen Y, Li Y. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 2015; 6(5):363-72; PMID:25894090; http://dx.doi.org/10.1007/s13238-015-0153-5
   PubMed Web of Science ®Google Scholar
• Cyranoski D, Reardon S. Embryo editing sparks epic debate. Nature 2014; 520:593-4; http://dx.doi.org/10.1038/520593a
   Web of Science ®Google Scholar